BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 30900217)

  • 21. The clinical significance of sCD14-ST for blood biomarker in neonatal hematosepsis: A diagnostic accuracy study.
    Xiao T; Chen LP; Zhang LH; Lai FH; Zhang L; Qiu QF; Que RL; Xie S; Wu DC
    Medicine (Baltimore); 2017 May; 96(18):e6823. PubMed ID: 28471985
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Presepsin (sCD14-ST) Is a Novel Marker for Risk Stratification in Cardiac Surgery Patients.
    Bomberg H; Klingele M; Wagenpfeil S; Spanuth E; Volk T; Sessler DI; Schäfers HJ; Groesdonk HV
    Anesthesiology; 2017 Apr; 126(4):631-642. PubMed ID: 28099244
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Physiological Variation in Plasma Presepsin Levels During the Early Neonatal Period.
    Ishii M; Hoshina T; Ichikawa S; Shimizu D; Araki S; Kinjo T; Shibata E; Hachisuga T; Kusuhara K
    Tohoku J Exp Med; 2018 Nov; 246(3):199-203. PubMed ID: 30487373
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessment of novel biomarkers: sTREM-1, pentraxin-3 and pro-adrenomedullin in the early diagnosis of neonatal early onset sepsis.
    Tunç T; Polat A; Özdemir R; Kiliçaslan B; Can E; Çelik HT; Arsan S; Kader Ş; Erol S; Uslu S; Özdemir ÖMA; ; Özcan B; Hanta D; Dilli D; Narter F; Gültekin N; Güzoğlu N; Aydemir Ö
    J Neonatal Perinatal Med; 2020; 13(1):47-54. PubMed ID: 31594258
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Presepsin for the Diagnosis of Neonatal Early-Onset Sepsis: A Systematic Review and Meta-analysis.
    Poggi C; Lucenteforte E; Petri D; De Masi S; Dani C
    JAMA Pediatr; 2022 Aug; 176(8):750-758. PubMed ID: 35639395
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Presepsin as a predictor of early onset neonatal sepsis in the umbilical cord blood of premature infants with premature rupture of membranes.
    Seliem W; Sultan AM
    Pediatr Int; 2018 May; 60(5):428-432. PubMed ID: 29495098
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Usefulness of presepsin (sCD14-ST) measurements as a marker for the diagnosis and severity of sepsis that satisfied diagnostic criteria of systemic inflammatory response syndrome.
    Shozushima T; Takahashi G; Matsumoto N; Kojika M; Okamura Y; Endo S
    J Infect Chemother; 2011 Dec; 17(6):764-9. PubMed ID: 21560033
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New Diagnostic Possibilities for Neonatal Sepsis.
    Tzialla C; Manzoni P; Achille C; Bollani L; Stronati M; Borghesi A
    Am J Perinatol; 2018 May; 35(6):575-577. PubMed ID: 29695000
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mean platelet volume in preterm: a predictor of early onset neonatal sepsis.
    Shaaban HA; Safwat N
    J Matern Fetal Neonatal Med; 2020 Jan; 33(2):206-211. PubMed ID: 29886794
    [No Abstract]   [Full Text] [Related]  

  • 30. Utility of serum resistin in the diagnosis of neonatal sepsis and prediction of disease severity in term and late preterm infants.
    Khattab AA; El-Mekkawy MS; Helwa MA; Omar ES
    J Perinat Med; 2018 Oct; 46(8):919-925. PubMed ID: 29605824
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multiplex Cytokine Profiling Identifies Interleukin-27 as a Novel Biomarker For Neonatal Early Onset Sepsis.
    He Y; Du WX; Jiang HY; Ai Q; Feng J; Liu Z; Yu JL
    Shock; 2017 Feb; 47(2):140-147. PubMed ID: 27648693
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Endocan - a potential diagnostic marker for early onset sepsis in neonates.
    Zonda GI; Zonda R; Cernomaz AT; Paduraru L; Avasiloaiei AL; Grigoriu BD
    J Infect Dev Ctries; 2019 Apr; 13(4):311-317. PubMed ID: 32045375
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of progranulin as a novel diagnostic biomarker for early-onset sepsis in neonates.
    Yang KD; He Y; Xiao S; Ai Q; Yu JL
    Eur J Clin Microbiol Infect Dis; 2020 Dec; 39(12):2405-2414. PubMed ID: 32720089
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Elevated levels of lipopolysaccharide-binding protein and soluble CD14 in plasma in neonatal early-onset sepsis.
    Berner R; Fürll B; Stelter F; Dröse J; Müller HP; Schütt C
    Clin Diagn Lab Immunol; 2002 Mar; 9(2):440-5. PubMed ID: 11874891
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Presepsin for the detection of early-onset sepsis in preterm newborns.
    Montaldo P; Rosso R; Santantonio A; Chello G; Giliberti P
    Pediatr Res; 2017 Feb; 81(2):329-334. PubMed ID: 27925621
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased serum concentration of soluble CD14 is a prognostic marker in gram-positive sepsis.
    Burgmann H; Winkler S; Locker GJ; Presterl E; Laczika K; Staudinger T; Knapp S; Thalhammer F; Wenisch C; Zedwitz-Liebenstein K; Frass M; Graninger W
    Clin Immunol Immunopathol; 1996 Sep; 80(3 Pt 1):307-10. PubMed ID: 8811052
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Soluble CD14 subtype (sCD14-ST) presepsin in critically ill preterm newborns: preliminary reference ranges.
    Mussap M; Puxeddu E; Burrai P; Noto A; Cibecchini F; Testa M; Puddu M; Ottonello G; Dessì A; Irmesi R; Gassa ED; Fanni C; Fanos V
    J Matern Fetal Neonatal Med; 2012 Oct; 25(Suppl 5):51-3. PubMed ID: 23025769
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The accuracy of presepsin (sCD14-ST) for the diagnosis of sepsis in adults: a meta-analysis.
    Zhang X; Liu D; Liu YN; Wang R; Xie LX
    Crit Care; 2015 Sep; 19(1):323. PubMed ID: 26357898
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Machine Learning Used to Compare the Diagnostic Accuracy of Risk Factors, Clinical Signs and Biomarkers and to Develop a New Prediction Model for Neonatal Early-onset Sepsis.
    Stocker M; Daunhawer I; van Herk W; El Helou S; Dutta S; Schuerman FABA; van den Tooren-de Groot RK; Wieringa JW; Janota J; van der Meer-Kappelle LH; Moonen R; Sie SD; de Vries E; Donker AE; Zimmerman U; Schlapbach LJ; de Mol AC; Hoffmann-Haringsma A; Roy M; Tomaske M; Kornelisse RF; van Gijsel J; Plötz FB; Wellmann S; Achten NB; Lehnick D; van Rossum AMC; Vogt JE
    Pediatr Infect Dis J; 2022 Mar; 41(3):248-254. PubMed ID: 34508027
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Circulating presepsin (soluble CD14 subtype) as a marker of host response in patients with severe sepsis or septic shock: data from the multicenter, randomized ALBIOS trial.
    Masson S; Caironi P; Fanizza C; Thomae R; Bernasconi R; Noto A; Oggioni R; Pasetti GS; Romero M; Tognoni G; Latini R; Gattinoni L
    Intensive Care Med; 2015 Jan; 41(1):12-20. PubMed ID: 25319385
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.